In terms of peripheral vascular disease, previous studies have demonstrated that Cyr61 is overexpressed in vascular smooth muscle cells of atherosclerotic lesions both in humans and in animal models [20, 34, 35] and could stimulate adhesion of vascular smooth muscle cells in a dose-dependent manner [11]. The gene discussed is CCN1; the disease is vascular disorder.